NEW ENGLAND JOURNAL OF MEDICINE r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe instname
Holman, R R, Bethel, M A, Mentz, R J, Thompson, V P, Lokhnygina, Y, Buse, J B, Chan, J C, Choi, J, Gustavson, S M, Iqbal, N, Maggioni, A P, Marso, S P, Öhman, P, Pagidipati, N J, Poulter, N, Ramachandran, A, Zinman, B, Hernandez, A F, EXSCEL Study Group & Serné, EH 2017, ' Effects of once-weekly exenatide on cardiovascular outcomes in type 2 diabetes ', New England Journal of Medicine, vol. 377, no. 13, pp. 1228-1239 . https://doi.org/10.1056/NEJMoa1612917 New England Journal of Medicine, 377(13), 1228-1239. Massachussetts Medical Society N Engl J Med
New England Journal of Medicine New England Journal of Medicine, Massachusetts Medical Society, 2011, 365 (23), pp.2167-77. ⟨10.1056/NEJMoa1110899⟩ Biblos-e Archivo. Repositorio Institucional de la UAM instname Goldhaber, S Z, Leizorovicz, A, Kakkar, A K, Haas, S K, Merli, G, Knabb, R M, Weitz, J I, ADOPT Trial Investigators & Husted, S 2011, ' Apixaban versus enoxaparin for thromboprophylaxis in medically ill patients ', Briefings from the New England Journal of Medicine, vol. 365, no. 23, pp. 2167-77 . https://doi.org/10.1056/NEJMoa1110899 Goldhaber, S Z, Leizorovicz, A, Kakkar, A K, Haas, S K, Merli, G, Knabb, R M, Weitz, J I, ADOPT Trial Investigators & Pedersen, C 2011, ' Apixaban versus enoxaparin for thromboprophylaxis in medically ill patients ', Briefings from the New England Journal of Medicine, vol. 365, no. 23, pp. 2167-77 . https://doi.org/10.1056/NEJMoa1110899